July 29, 2016 8:09 AM ET


Company Overview of Dance BioPharm Inc.

Company Overview

Dance Biopharm Inc., a development stage biopharmaceutical company, focuses on the development of inhaled insulin products for the treatment of diabetes worldwide. Its lead product candidate includes Dance 501, a drug/device combination product to deliver a high purity liquid insulin formulation through a small handheld electronic inhaler that has completed Phase II clinical trials in adult patients with type 2 diabetes. The company was formerly known as Dance Pharmaceuticals, Inc. and changed its name to Dance Biopharm Inc. in February 2013. Dance Biopharm Inc. was founded in 2009 and is based in Brisbane, California.

150 North Hill Drive

Suite 24

Brisbane, CA 94005

United States

Founded in 2009

17 Employees



Key Executives for Dance BioPharm Inc.

Chairman, Chief Executive Officer and Founder
Age: 68
President and Director
Age: 56
Chief Financial Officer, Principal Accounting Officer and Vice President of Administration
Age: 45
Executive Vice President of Operations and Quality
Age: 63
Chief Business Officer and Director
Age: 51
Compensation as of Fiscal Year 2016.

Dance BioPharm Inc. Key Developments

Dance BioPharm Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 02:00 PM

Dance BioPharm Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 02:00 PM. Venue: The Encore at Wynn, 3131 S Las Vegas Blvd, Las Vegas, NV 89109, United States.

Dance Biopharm Inc. Appoints Dr. Tyler Martin to the Position of President and Director

Dance Biopharm Inc. announced the appointment of J. Tyler Martin, M.D., to the newly created position of president. Dr. Martin has also been appointed to the board of directors. He brings more than 20 years of experience in the biotechnology industry to Dance, where he oversees company operations, reporting to Dr. John Patton, CEO. Dr. Martin's most recent corporate position was with Dynavax Technologies, where he joined as chief medical officer in 2009 and then became president in 2010 and a member of the board of directors. He served as president until 2013 when he left to pursue a position as founder and CEO of Great Plains Biotechnology. He also serves as a director of Adjuvance Technologies.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dance BioPharm Inc., please visit www.dancebiopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.